The proMMP-2 activation rate in patients with chronic viral liver diseaseMURAWAKI, Yoshikazu; IKUTA, Yujiro; KODA, Masahiko et al.Clinica chimica acta. 2002, Vol 324, Num 1-2, pp 99-103, issn 0009-8981Article

Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivoZOPF, Steffen; NEUREITER, Daniel; BOURALEXIS, Steve et al.International journal of oncology. 2007, Vol 31, Num 6, pp 1391-1402, issn 1019-6439, 12 p.Article

Inclusion body myositis associated with hepatitis C virus infectionKASE, Satoru; SHIOTA, Goshi; KAWASAKI, Hironaka et al.Liver (Copenhagen). 2001, Vol 21, Num 5, pp 357-360, issn 0106-9543Article

Effect of ALDH2 and CYP2E1 gene polymorphisms on drinking behavior and alcoholic liver disease in Japanese male workersOKAMOTO, Kinya; MURAWAKI, Yoshikazu; YUASA, Isao et al.Alcoholism, clinical and experimental research. 2001, Vol 25, Num 6, pp 19S-23S, issn 0145-6008, SUPConference Paper

The dual EGF/VEGF receptor tyrosine kinase inhibitor AEE788 inhibits growth of human hepatocellular carcinoma xenografts in nude miceOKAMOTO, Kinya; NEUREITER, Daniel; KAUFMANN, Bernhard et al.International journal of oncology. 2008, Vol 33, Num 4, pp 733-742, issn 1019-6439, 10 p.Article

Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma a randomized control studyKODA, Masahiko; MURAWAKI, Yoshikazu; MITSUDA, Akeri et al.Cancer. 2001, Vol 92, Num 6, pp 1516-1524, issn 0008-543XArticle